
Diversified Healthcare Trust DHC.OQ DHC.O is expected to show a rise in quarterly revenue when it reports results on February 25 for the period ending December 31 2024
The Newton Massachusetts-based company is expected to report a 2.6% increase in revenue to $370.971 million from $361.54 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data. (SAL represents Total Revenue)
LSEG's mean analyst estimate for Diversified Healthcare Trust is for a loss of 29 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Diversified Healthcare Trust is $2.00, below its last closing price of $2.62.
This summary was machine generated February 21 at 22:20 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)